The IMMUNE Building Standardhas been developed as a set of measures, technical solutions, and facility management practices to certify how built environments can withstand present and future health challenges and minimize the impact of a pandemic such as COVID-19 and other bacteriological or toxicological threats.
Early case reports and epidemiological studies of groups where SARS-CoV-2 has led to outbreaks of COVID-19 indicates that the primary means of disease transmission is the indoor spread of exhaled droplet aerosols.